NOVA PNEUMA
PharmaNOVA PNEUMA is a pharmaceutical company focused on Neurology. Key products include ADASUVE.
NOVA PNEUMA's Key Drugs
NOVA PNEUMA's core commercial portfolio centers on ADASUVE, spanning Neurology — its most strategically important drugs approved in the last 15 years.
NOVA PNEUMA's Recent FDA Approvals
New NDA/BLA approvals for NOVA PNEUMA over the last two years — novel drugs only, excluding generics and label supplements.
NOVA PNEUMA's Therapeutic Areas
NOVA PNEUMA's approved drugs and pipeline span 1 therapeutic area, led by Neurology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
NOVA PNEUMA's Top Competitors
NOVA PNEUMA's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
NOVA PNEUMA Pipeline Snapshot
NOVA PNEUMA has 1 active clinical program from ClinicalTrials.gov — 0 Phase 3, 1 Phase 2 and 0 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • ADASUVE leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2012-12-21
- Latest
- 2022-01-27
- Applications
- 1